Endocrine Adverse Reactions of Tyrosine Kinase Inhibitors in Combination With Immune Checkpoint Inhibitors
EARs were more common in TKIs + ICIs therapy. The distribution of EARs in different glands varied among combination therapy and monotherapy. Combination therapy-associated EARs did not increase the risk of mortality.
Authors
- Y Q Zhang (ORCID: https://orcid.org/0000-0002-2925-3859)
- Difei Lu (ORCID: https://orcid.org/0000-0003-3953-8900)
- Kaiwei Yang (ORCID: https://orcid.org/0000-0003-4228-2571)
- Junqing Zhang (ORCID: https://orcid.org/0000-0002-8574-1945)
- Ying Gao (ORCID: https://orcid.org/0000-0002-9156-9483)
- Wen Shao (ORCID: https://orcid.org/0000-0002-2922-4118)
Institutions
- Peking University (CN)
- Peking University First Hospital (CN)
Publication Details
- Journal
- The Journal of Clinical Endocrinology & Metabolism
- Published
- 2025-02-22
- DOI
- https://doi.org/10.1210/clinem/dgaf117
- Citations
- 3
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 4.06